1LyMwl4

62 REVISTA ARGENTINA DE CARDIOLOGÍA / VOL 83 SUPLEMENTO 2 / JUNIO 2015
7. Falconi M, Oberti P, Tewel F, Pizarro R, Krauss J, Cagide A. Evaluación
seriada de pacientes asintomáticos con insuficiencia aórtica
grave y función ventricular normal: estudio basado en el tamaño
ventricular y en la lesión valvular. Rev Argent Cardiol 2006;74:281-8.
8. Detaint D, Messika-Zuiton D, Maalouf J, Tribouilloy C, Mahoney
D, Tajik A, et al. Quantitative echocardiographic determinants of
clinical outcome in asymptomatic chronic aortic regurgitation. J Am
Coll Cardiol Imag 2008;1:1-11.
9. Pizarro R, Bazzino O, Oberti P, Falconi M, Arias A, Krauss J, et al.
Prospective validation of the prognostic usefulness of B-type natriuretic
peptide in asymptomatic patients with chronic severe aortic
regurgitation. J Am Coll Cardiol 2011;58:1705-14.
10. Esper R, Madoery R. Progresos en auscultación y fonomecanocardiografía.
Buenos Aires: López Editores, 1974.
11. Fishleder BL. Insuficiencia aórtica. En: Exploración cardiovascular
y fonomecanocardiografía clínica. 2. a ed. La Prensa Médica
Mexicana; 1978.
12. Weyman AE. Principles and practice of echocardiography. 2 nd ed.
Philadelphia, USA: Lea & Febiger; 1994:528-43.
13. Feigenbaum H. Echocardiography. 5 th ed. Philadelphia, USA: Lea
& Febiger; 1994:282-91.
14. Perry GJ, Helmcke F, Nanda NC, Byard C, Soto B. Evaluation
of aortic insufficiency by Doppler color flow mapping. J Am Coll
Cardiol 1987;9:952-9.
15. Reynolds T, Abate J, Tenney A, Warner MG. The JH/LVOH
method in the quantification of aortic regurgitation: how the cardiac
sonographer may avoid an important potential pitfall. J Am Soc Echo
1991;4:105-8.
16. Samstad SO, Hegrenaes L, Skjaerpe T, Hatle L. Half time of the
diastolic aortoventricular pressure difference by continous wave Doppler
ultrasound: a measure of the severity of aortic regurgitation? Br
Heart J 1989;61:336-43.
17. Vandervoort PM, Rivera M, Mele D, Palacios IF, Dinsmore RE,
Weyman AE, Levine RA, Thomas JD. Application of color Doppler
flow mapping to calculate effective regurgitant orifice area. An in vitro
study and initial clinical observations. Circulation 1993;88:1150-6.
18. Enriquez-Sarano M, Seward JB, Bailey KR, Tajik J. Effective
regurgitant orifice area: A noninvasive Doppler development of an
old hemodynamic concept. J Am Coll Cardiol 1994;23:443-51.
19. Takenaka K, Dabestani A, Gardin JM, Russell D, Clark S, Allfie
A, et al. A simple Doppler echocardiographic method for estimating
severity of aortic regurgitation. Am J Cardiol 1986;57:1340-3.
20. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft
CD, Levine RA, et al. Recommendations for evaluation of the severity
of native valvular regurgitation with two-dimensional and Doppler
echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
21. Pridie RB, Benham R, Oakley CM. Echocardiography of the mitral
valve in aortic valve disease. Br Heart J 1971;33:296-304.
22. Page A, Layton C. Premature opening of aortic valve in severe
aortic regurgitation. Br Heart J 1975;37:1101-14.
23. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA,
Bierman FZ, et al. ACC/AHA guidelines for the clinical application
of echocardiography: a report of the American College of Cardiology
/ American Heart Association Task Force on Practice Guidelines
(Committee on Clinical Application of Echocardiography). Circulation
1997;95:1686-744.
24. Otto CM. The practice of clinical echocardiography. Philadelphia,
Pennsylvania: Saunders; 1997.
25. Gaasch WH, Carroll JD, Levine HJ, Criscitiello MG. Chronic
aortic regurgitation: pronostic value of left ventricular end-systolic
dimension and end-diastolic radius/thickness ratio. J Am Coll Cardiol
1983;1:775-82.
26. Bierbach BO, Aicher D, Issa OA, Bomberg H, Gräber S, Glombitza
P, et al. Aortic root and cusp configuration determine aortic valve
function. Eur J Cardiothorac Surg 2010;38:400-6.
27. Beller GA. Radionuclide imaging in valvular heart disease. Clinical
nuclear cardiology. WB Saunders Company 1995;12:373.
28. Cornyn JW, Massie BM, Greenberg B, Loge DL, Thomas D, Bristow
JD, et al. Reproducibility of rest and exercise left ventricular ejection
fraction and volumes in chronic aortic regurgitation. Am J Cardiol
1987;59:1361-6.
29. Bonow RO. Radionuclide angiography in the management of
asymptomatic aortic regurgitation. Circulation 1991;84:1296-302.
30. Bonow RO, Rosing DR, McIntosh CL, Jones M, Maron BJ, Lan
KK, et al. The natural history of asymptomatic patients with aortic
regurgitation and normal left ventricular function. Circulation
1983;68:509-17.
31. Borer J, Hochreiter C, Herrold E, Supino P, Aschermann M,
Wencker D, et al. Prediction of indications for valve replacement
among asymptomatic or minimally symptomatic patients with chronic
aortic regurgitation and normal left ventricular performance. Circulation
1998;97:525-34.
32. Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr
JC, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/ SIR 2006
appropriateness criteria for cardiac computed tomography and cardiac
magnetic resonance imaging: a report of the American College
of Cardiology Foundation/American College of Radiology, Society of
Cardiovascular Computed Tomography, Society for Cardiovascular
Magnetic Resonance, American Society of Nuclear Cardiology, North
American Society for Cardiac Imaging, Society for Cardiovascular
Angiography and Interventions, and Society of Interventional Radiology.
J Am Coll Cardiol 2006;48:1475-97.
33. Taylor AJ, Cequeira M, Hodgson JM, Mark D, Min J, O’Gara P,
et al. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010
appropriate use criteria for cardiac computed tomography: a report
of the American College of Cardiology Foundation Appropriate Use
Criteria Task Force, the Society of Cardiovascular Computed Tomography,
the American College of Radiology, the American Heart
Association, the American Society of Echocardiography, the American
Society of Nuclear Cardiology, the Society for Cardiovascular Angiography
and Interventions, and the Society for Cardiovascular Magnetic
Resonance. J Am Coll Cardiol 2010;56:1864-94.
34. Bonow RO, Borer JS, Rosing DR, Henry WL, Pearlman AS, McIntosh
CL, et al. Preoperative exercise capacity in symptomatic patients
with aortic regurgitation as a predictor of postoperative left ventricular
function and long-term prognosis. Circulation 1980;62:1280-90.
35. Escudero EM, Martire VD, Mele AA. Utilidad de la ergometría para
valorar la función ventricular izquierda en la insuficiencia aórtica.
Arch Inst Cardiol México 1985;55:235-41.
36. Bonow R, Cheitlin M, Crawford M, Douglas P. Task Force 3:
Valvular Heart Disease. 36th Bethesda Conference. Eligibility
Recommendations for Competitive Athletes With Cardiovascular
Abnormalities. J Am Coll Cardiol 2005;45:1334-40.
37. Cohn L, Mason DT, Ross J, Morrow AG, Braunwald E. Preoperative
assessment of aortic regurgitation in patients with mitral valve
disease. Am J Cardiol 1967;19:177-82.
38. Perloff JK. Acute severe aortic regurgitation: recognition and
management. J Cardiovasc Med 1983;8:209.
39. Martínez Martínez JA, Suárez LD, Perosio AM. Insuficiencia
aórtica aguda grave. Buenos Aires: Editorial Científica Interamericana;
1986.
40. Miller R, Vismara L, DeMaria A, Salel A, Mason D. Afterload
reduction therapy with nitroprusside in severe aortic regurgitation:
improved cardiac performance and reduced regurgitant volumen. Am
J Cardiol 1976;38:564-7.
41. Dajani A, Taubert K, Wilson W, Bolger A, Bayer A, Ferrieri P. Prevention
of bacterial endocarditis. Recomendations by the American
Heart Association. Circulation 1997;96:358-66.
42. Greenberg B, Massie B, Bristow JD, Cheitlin M, Siemienczuk D,
Topic N, et al. Long-term vasodilator therapy of chronic aortic insufficiency:
a randomized double-blind, placebo-controlled clinical trial.
Circulation 1988;78:92-103.
43. Scognamiglio R, Rahimtoola S, Fasoli G, Nistri S, Dalla Volta S.
Nifedipine in asymptomatic patients with severe aortic regurgitation
and normal left ventricular function. N Engl J Med 1994;331:689-94.
44. Scognamiglio R, Negut C, Palisi M, Fasoli G, Dalla-Volta S. Long-